Showing results (31-40 of 45) with videos related to
Sort By:
Pageof 5
Oncology Letters|May 9, 2022
Tyrosine kinase inhibitors in sarcoma treatmentAnastasios Kyriazoglou, Lydia Evangelia Gkaralea, Ioannis Kotsantis, et al.Cancers|April 30, 2021
Systematic Review of Recurrent Osteosarcoma Systemic TherapyIoanna Gazouli, Anastasios Kyriazoglou, Ioannis Kotsantis, et al.International Journal of Cardiology|May 9, 2022
Endothelial glycocalyx integrity in oncological patientsKalliopi Keramida, John Thymis, Maria Anastasiou, et al.Plos One|May 10, 2019
HPV16 E6/E7 expression in circulating tumor cells in oropharyngeal squamous cell cancers: A pilot studyPanagiota Economopoulou, George Koutsodontis, Margaritis Avgeris, et al.Cancers|January 20, 2021
Patterns of Response to Immune Checkpoint Inhibitors in Association with Genomic and Clinical Features in Patients with Head and Neck Squamous Cell Carcinoma (HNSCC)Panagiota Economopoulou, Maria Anastasiou, George Papaxoinis, et al.British Journal of Cancer|May 23, 2025
Association of DNA damage response signals and oxidative stress status with nivolumab efficacy in patients with Head and Neck Squamous Cell CarcinomaChristina Papanikolaou, Panagiota Economopoulou, Aris Spathis, et al.ESMO Open|May 17, 2020
Prognostic impact of indoleamine 2,3-dioxygenase 1 (IDO1) mRNA expression on circulating tumour cells of patients with head and neck squamous cell carcinomaPanagiota Economopoulou, Athina Kladi-Skandali, Areti Strati, et al.Cancers|April 23, 2022
A Multicenter, Prospective, Observational Study to Assess the Clinical Activity and Impact on Symptom Burden and Patients' Quality of Life in Patients with Advanced Soft Tissue Sarcomas Treated with Trabectedin in a Real-World Setting in GreeceStefania Kokkali, Ioannis Boukovinas, Epaminondas Samantas, et al.Oral Oncology|June 11, 2019
Surrogates of immunologic cell death (ICD) and chemoradiotherapy outcomes in head and neck squamous cell carcinoma (HNSCC)Panagiota Economopoulou, George Koutsodontis, Areti Strati, et al.Oral Oncology|March 5, 2023
Next-generation sequencing (NGS) profiling of matched tumor and circulating tumor DNA (ctDNA) in head and neck squamous cell carcinoma (HNSCC)Panagiota Economopoulou, Aris Spathis, Ioannis Kotsantis, et al.Pageof 5